Firdapse Approval Expanded to Children With Lambert-Eaton Myasthenic Syndrome

The FDA has expanded the approval of Firdapse to include patients 6 years of age and older with Lambert-Eaton myasthenic syndrome.

Related Keywords

Patrickj Mcenany , ,Catalyst Pharmaceuticals ,Drug Administration ,New Drug Application ,